Introduction
Wnt genes constitute one of the major families of developmentally signi®cant signaling molecules, controlling a variety of processes such as cell fate speci®cation, cell migration and cell polarity (reviewed by Cadigan and Nusse, 1997) . It is now clear that Wnt genes are not functionally equivalent and may exert their diverse eects through activation of distinct intracellular signaling pathways (reviewed by . Examination of Wnt gene function in a variety of organisms has provided insights into the molecular mechanics of two of these signaling pathways. In one pathway, Wnt proteins function through cell surface receptors and an intracellular signaling pathway to`activate' b-catenin, a multi-functional protein that acts in the context of Wnt signaling to modulate transcription of speci®c target genes. In the second pathway, Wnt proteins function via cell surface receptors to stimulate an increase in intracellular Ca 2+ and the subsequent activation of protein kinase C (PKC). Although it appears that dierent Wnt proteins preferentially activate one of these two pathways, this distinction is not absolute, as the activity of Wnt proteins likely depends on the repertoire of receptors and other co-factors present at the cell surface Larabell et al., 1997) . Since Wnt proteins can activate more than one signaling pathway, we propose the names Wnt/b-catenin and Wnt/Ca 2+ , which emphasize the downstream eectors, to describe these distinct signal transduction pathways. The Wnt/bcatenin and Wnt/Ca 2+ pathways will serve as a paradigm for elucidating the many roles Wnt genes play in development and the mechanisms by which the mis-regulation of Wnt signaling lead to human cancer. In this review, we will summarize our current understanding of the Wnt/b-catenin and Wnt/Ca 2+ pathways. We have emphasized the latest advances in the ®eld and pay particular attention to the molecular mechanisms underlying each of these pathways and how Wnt signaling contributes to human cancer. For additional literature, we refer the reader to several recent reviews for information on the function of Wnt signaling in development (reviewed by Cadigan and Nusse, 1997; . Owing to the rapid progress in this ®eld, we apologize to those researchers whose data may have been omitted from this review due to limitations on space.
The Wnt gene family
Wnt genes encode secreted signaling proteins that share overall sequence identity and a conserved pattern of 23 ± 24 cysteine residues ( Figure 1 ). The original members of the Wnt gene family are mouse Wnt-1 and Drosophila wingless (wg). Wnt-1 was identi®ed as a gene activated in response to insertion of mouse mammary tumor virus whose over-expression in the mammary gland contributes to tumor formation van Ooyen and Nusse, 1984) . wg was identi®ed genetically and mutations in the wg locus resulted in embryonic lethality and severe patterning defects (Nusslein-Volhard and Wieschaus, 1980) . Orthologs of Wnt-1 and wg have since been found in many organisms from C. elegans to humans, with each organism possessing multiple related Wnt genes. For example, Drosophila possesses four and mouse at least 18 Wnt genes. A list of known Wnt genes can be found in Cadigan and Nusse (1997) and on the Wnt gene homepage (http://www-leland.stanford.edu/*rnusse/ wntwindow.html). This site also includes sequence alignments of many Wnt genes.
of Wnt receptors remained elusive, leaving a large gap in our understanding of Wnt signaling. This black box has now been replaced with the ®nding that members of the Frizzled gene family can function as Wnt receptors ( Figure 1 ; Bhanot et al., 1996 Bhanot et al., , 1999 Bhat, 1998; Kennerdell and Carthew, 1998; Muller et al., 1999; Wang et al., 1996; Yang-Snyder et al., 1996) . Frizzled genes encode seven-transmembrane proteins (Adler et al., 1990; Park et al., 1994; Wang et al., 1996) with an amino-terminal cysteine-rich domain (CRD) that binds Wnts with high anity (Hsieh et al., 1999b) . Like the Wnt gene family, members of the Frizzled gene family have been identi®ed in organisms with each organism possesses multiple Frizzled genes. A list of known Frizzled genes and sequence alignments can be found on the Wnt gene homepage (http:/wwwleland.stanford.edu/*rnusse/wntwindow.html).
Although compelling evidence exists that Frizzleds act as Wnt receptors, it is becoming clear that other cell surface and extracellular molecules also play crucial roles in the reception of Wnt signals. In Drosophila, mutations in genes encoding the core protein of glypican, a heparan sulfate proteoglycan, or enzymes involved in the biosynthesis of heparan sulfate have been shown to impair wg signaling during embryogenesis (Binari et al., 1997; Hacker et al., 1997; Haerry et al., 1997; Lin and Perrimon, 1999; Tsuda et al., 1999) . Sulfated glycosaminoglycans are also required for optimal Wg activity in Drosophila cell lines (Reichsman et al., 1996) and for Xwnt-8 activity in Xenopus embryos (Itoh and Sokol, 1994) . These data support the idea that proteoglycans are an integral part of a Wnt receptor complex. At this time it is unclear whether proteoglycans play a role in sequestration, presentation or reception of Wnt signals. Further biochemical analyses of the Wnt reception complex should clarify the relationship between proteoglycans and Wnt signal transduction.
Wnt function is also modulated extracellularly through interaction with a diverse group of secreted Wnt inhibitors. At present, these Wnt inhibitors include members of the secreted Frizzled-Related Protein family (called FrzB or FRP; Finch et al., 1997; Leyns et al., 1997; Rattner et al., 1997; , Wnt-inhibitory factor-1 (WIF-1; Hsieh et al., 1999a) , Cerberus (Bouwmeester et al., 1996; Piccolo et al., 1999) , and Dickkopf (Fedi et al., 1999; Glinka et al., 1998 For Wnt and Frizzled:`s' indicates signal sequence; and`c' indicates conserved cysteines. The CRD domain of Frizzled is de®ned as the cysteine rich domain. The DIX domain, identi®ed in both Dishevelled and Axin, is important for homodimerization. Dishevelled also contains a PDZ domain and a DEP domain. The DEP domain has been found in proteins that regulate GTPases and in Dishevelled has been shown to be required for recruitment of Dishevelled to the plasma membrane. Axin contains a RGS domain, which has been found in proteins that regulate G-protein signaling. Binding regions for APC, GSK-3, b-catenin and PP2A on Axin are indicated. APC is comprised of the following domains: a N-terminal region required for multimerization; seven armadillo repeats; a region consisting of 15 amino acid repeats that contains a b-catenin binding site; a region consisting of 20 amino acid repeats that contains another b-catenin binding site; interspersed between the 20 amino acid repeats are SAMP repeats that are required for binding Axin; and ®nally a basic microtubule binding region. The destruction box of b-catenin contains phosphorylation sites for GSK-3 and ubiquitination sites. APC, Axin and LEF/TCF binding sites have been mapped to the armadillo repeats of b-catenin. TCF contains a nuclear localization signal (NLS). It also contains a HMG box, which is a DNA binding motif. Binding sites for b-catenin, Groucho and CtBP on TCF are indicated formation of a non-functional complex with Frizzled receptors . The mechanism of Dickkopf function, however, is unknown. Interestingly, Cerberus is not only an inhibitor of Wnt, but is also an antagonist of Nodal and Bone Morphogenetic Protein (BMP) activity suggesting that it can function as a multi-valent antagonist of growth factor signaling (Piccolo et al., 1999) .
The Wnt/b-catenin pathway
At the heart of the Wnt/b-catenin pathway is bcatenin, a multi-functional protein with independent roles in cadherin-mediated cell adhesion and Wnt signal transduction (Figure 1 , reviewed by Miller and Moon, 1996; Willert and Nusse, 1998(www.stke.org) ). The ultimate result of Wnt/b-catenin pathway activation is the formation of a free, signaling pool of bcatenin in the cell that enters the nucleus and forms a complex with members of the LEF/TCF family of transcription factors to regulate expression of target genes. This is accomplished by controlling the stability of b-catenin. In the absence of Wnt signals, b-catenin is ubiquitinated and degraded by the proteasome pathway, keeping the levels of free b-catenin low (Figure 2) . Activation of the Wnt/b-catenin pathway prevents ubiquitination of b-catenin and leads to the generation of a signaling pool of b-catenin in the cell (Figure 2 ). Although this scheme appears simple, recent studies have uncovered an increasing number of proteins that play a role in regulating b-catenin stability and the mechanism by which these proteins regulate b-catenin stability has proven to be a complex problem.
The Wnt/b-catenin pathway has been intensely studied in a variety of organisms and a general understanding of the molecular signal transduction pathway has been elucidated. Components of the Wnt/ b-catenin pathway were originally identi®ed as mutations that produced patterning defects similar to or opposite of those seen in wg mutant embryos (reviewed by Cadigan and Nusse, 1997) . More recently, biochemical, yeast-two-hybrid and activity-based screens have identi®ed several additional components of the pathway (Rubinfeld et al., 1993; Su et al., 1993; Yost et al., 1998; Zeng et al., 1997) . With these molecules in hand, a variety of approaches have been used to understand how these proteins regulate Wnt signaling and order these proteins into a signal transduction pathway. Although the Wnt/b-catenin pathway was once thought of as a linear pathway progressing from the plasma membrane to the nucleus, these studies have shown that the pathway may be better described as a dynamic complex of proteins, coordinately acting to regulate steady-state levels of bcatenin in the cell.
The destruction complex: GSK-3, Axin, APC, and
The elaborate complex of proteins that, in the absence of Wnt signals, promotes the ubiquitination and subsequent degradation of b-catenin via the proteasome is a current focus of study in the Wnt signaling ®eld. Presently, four proteins have been identi®ed that directly promote the degradation of b-catenin: GSK-3, Axin, APC, and b-TrCP/Slimb. These proteins comprise the`destruction complex' and function to maintain low steady-state levels of b-catenin in the cell. In its simplest form, Axin and APC serve as scaolds, binding both b-catenin and GSK-3 and facilitating the phosphorylation of b-catenin by GSK-3. GSK-3 is thought to phosphorylate one or more conserved serine and threonine residues in the amino-terminal region of b-catenin (S33, S37, T41, and S45 in human b-catenin). These phospho-amino acids act as a tag, promoting interaction of b-catenin with b-TrCP/Slimb, a component of the SCF ubiquitin ligase complex. Ubiquitination of b-catenin then serves as a second tag, marking it for destruction by the proteasome. Using this model as a guide, we will examine the role each component of the destruction complex plays in regulating steady-state levels of b-catenin.
The central player in the destruction complex is GSK-3, a serine/threonine kinase which is an essential negative regulator of the Wnt/b-catenin pathway. Mutation of zw3, the Drosophila ortholog of GSK-3, results in accumulation of Armadillo, the Drosophila ortholog of b-catenin, and phenotypes that mimic It is apparent that the composition of this complex is dynamic with movement of protein in and out of the complex resulting in distinct functional consequences. It is also evident that proteins are still being identi®ed that are critical for Wnt/b-catenin signaling. Therefore, we acknowledge that this schematic is a simpli®cation of the current model of the Wnt/b-catenin pathway that is discussed in detail in the text. In the absence of Wnt Gsk-3 phosphorylates b-catenin. This phosphorylation is facilitated by Axin and APC. Phosphorylation of b-catenin targets it for ubiquitination by b-TrCP resulting in the proteosomal degradation of b-catenin. In the absence of Wnt, some members of TCF/ LEF family of transcription factors act as a repressor through interaction with the co-repressors, Groucho, CBP and CtBP. In contrast, in the presence of Wnt signaling, Dishevelled (Dsh) and GBP inhibit phosphorylation of b-catenin by GSK-3. The molecular mechanism for this inhibition is unclear but may involve either direct downregulation of GSK-3 activity or modi®cation of the composition of the complex. Consequently, a free pool of b-catenin accumulates in the cytoplasm and is now available to translocate it to the nucleus. Nuclear b-catenin binds TCF/LEF and activates transcription of target genes constitutive activation of the Wnt/b-catenin pathway (Peifer et al., 1994; Siegfried et al., 1992 Siegfried et al., , 1994 . Similarly, over-expression of a kinase dead mutant of GSK-3 in Xenopus promotes the stabilization and nuclear accumulation of b-catenin Yost et al., 1996) . GSK-3 can phosphorylate one or more highly conserved serine and threonine residues near the amino-terminus of b-catenin in vitro and mutation of these putative GSK-3 sites in b-catenin signi®cantly diminishes its phosphorylation in vitro and in vivo (Yost et al., 1996) . These residues are part of the`destruction box' sequence that is required for A Morin et al., 1997; Samowitz et al., 1999; Sparks et al., 1998) ; B ; C (Blaker et al., 1999) ; D (de La Coste et al., 1998; Legoix et al., 1999; Miyoshi et al., 1998) ; E (Iwao et al., 1999) ; F (Zurawel et al., 1998) ; G (Gamallo et al., 1999; Palacios and Gamallo, 1998; Sagae et al., 1999; Wright et al., 1999) ; H (Chan et al., 1999) ; I (Voeller et al., 1998) ; J (Iwao et al., 1999) ; (Koesters et al., 1999) ; *multiple mutations were found in two samples targeted degradation. Mutation or deletion of these serine and threonine residues in the destruction box results in highly stable forms of b-catenin that are constitutively active (Pai et al., 1997; Yost et al., 1996) . The importance of the destruction box sequence is highlighted by the recent ®nding that residues in the destruction box of b-catenin are often mutated in a variety of human cancers ( Figure 3 , discussed in detail below).
Although GSK-3 plays a crucial role in regulating bcatenin stability, it does not bind b-catenin directly and requires two additional proteins, Axin and APC, to facilitate its interaction with b-catenin. Axin is the product of the fused locus in mice and encodes a modular protein that interacts with a variety of signaling proteins including APC, b-catenin, GSK-3 and Dishevelled ( Figure 1 , Behrens et al., 1998; Fagotto et al., 1999; Hart et al., 1998; Ikeda et al., 1998; Itoh et al., 1998; Kishida et al., 1998; Nakamura et al., 1998; Sakanaka et al., 1998; Yamamoto et al., 1998; Zeng et al., 1997) . Axin possesses two conserved domains, an amino-terminal RGS (Regulator of Gprotein Signaling) domain and a carboxy-terminal DIX domain (found in Axin and Dishevelled; Cadigan and Nusse, 1997) . RGS domains are found in a group of proteins known to regulate signaling through heterotrimeric G-proteins (reviewed by Dohlman and Thorner, 1997), although there is no evidence that Axin interacts with G-proteins. The RGS domain, however, is required for the binding of APC (Behrens et al., 1998; Hart et al., 1998; Kishida et al., 1998; Nakamura et al., 1998) and deletion of the RGS domain results in the production of a dominantnegative Axin protein (Zeng et al., 1997) . The central region of Axin binds b-catenin and GSK-3 through distinct binding sites (Behrens et al., 1998; Hart et al., 1998; Ikeda et al., 1998; Itoh et al., 1998; Sakanaka et al., 1998; Yamamoto et al., 1998) . The carboxy terminal region appears to be important for homodimerization (Hsu et al., 1999; Kishida et al., 1999; Sakanaka and Williams, 1999) and for interactions with Protein Phosphatase 2A (PP2A; Hsu et al., 1999) and Dishevelled (Hsu et al., 1999; Kishida et al., 1999) .
The proposed function of Axin is to act as a bridge between GSK-3 and b-catenin, facilitating GSK-3-dependent phosphorylation and the subsequent degradation of b-catenin. Consistent with this proposed role, expression of Axin in mammalian cells is sucient to reduce steady-state levels of b-catenin (Behrens et al., 1998; Hart et al., 1998; Kishida et al., 1998) and inhibits Wg signaling in Drosophila (Hamada et al., 1999; Willert et al., 1999a) . Furthermore, Axin was found to promote GSK-3-mediated phosphorylation of b-catenin in vitro Yamamoto et al., 1998) . The function of Axin in down-regulating bcatenin may itself be regulated by GSK-3. Axin is a substrate for GSK-3 and phosphorylation of Axin by GSK-3 can increase the stability of Axin in the cell ). An additional mode of modulating Axin activity may be through regulation of Axin/b-catenin interactions. Willert et al. (1999b) demonstrated that the state of Axin phosphorylation correlated with changes in the ability of Axin to bind b-catenin. Phosphorylated Axin was found to bind b-catenin more eectively than dephosphorylated Axin (Willert et al., 1999b) . Lithium, a potent inhibitor of GSK-3, promoted the dephosphorylation of Axin providing evidence that GSK-3-mediated phosphorylation of Axin may play a role in modulating Axin/b-catenin interactions (Willert et al., 1999b) .
APC was originally identi®ed as a tumor suppressor protein and mutations in APC are implicated in colorectal cancer (reviewed by Polakis, 1997) . The APC gene encodes a large, modular protein that binds to several components of the Wnt/b-catenin pathway, including b-catenin, GSK-3, and Axin (Figure 1) . Insight into the function of APC came from the ®nding that colorectal adenocarcinoma cell lines harboring mutations in the APC gene possess high levels of b-catenin (Munemitsu et al., 1995) . Expression of wild-type APC in these cells resulted in a dramatic reduction in b-catenin levels suggesting that APC is negative regulator of b-catenin stability (Munemitsu et al., 1995) .
Current models predict that APC functions in a similar fashion to Axin, facilitating GSK-3-mediated phosphorylation of b-catenin and stimulating its subsequent degradation (reviewed by Moon and Miller, 1997; Polakis, 1997) . Consistent with this idea, expression of APC in colon carcinoma cell can promote the degradation of b-catenin (Hayashi et al., 1997; Munemitsu et al., 1995) . However, overexpression of APC in Xenopus results in phenotypes that mimic activation of the Wnt/b-catenin pathway suggesting that APC can also have a positive signaling Figure 4 Schematic representation of the Wnt/Ca 2+ pathway. The current model for the Wnt/Ca 2+ pathway is that Rat Frizzled-2 and several mouse Frizzled homologs (Sheldahl et al., 1999) (Kitagawa et al., 1999; Liu et al., 1999; Winston et al., 1999) . Interaction of b-catenin with the SCF b-TrCP ubiquitin ligase complex then results in ubiquitination of bcatenin (Kitagawa et al., 1999; Orford et al., 1997) , which then targets it for proteolysis by the 26S proteasome (Orford et al., 1997) . Evidence for this model comes from studies examining the eects of bTrCP/Slimb on Wnt/b-catenin signaling in Drosophila and Xenopus. Loss of slimb function in Drosophila results in ectopic activation of the Wnt/b-catenin pathway and accumulation of high levels of Armadillo (Jiang and Struhl, 1998) . In Xenopus, over-expression of b-TrCP/Slimb inhibits Xwnt-8 activity (Marikawa and Elinson, 1998) and over-expression of a dominantnegative version stabilizes b-catenin and activates Wnt/ b-catenin target genes (Lagna et al., 1999; Liu et al., 1999; Marikawa and Elinson, 1998) .
The story of b-catenin appears to have other characters, as additional regulators have entered the fray in the past year. For example, a potential role for PP2A in regulating b-catenin stability was uncovered by Seeling et al. (1999) . Expression of the B56a regulatory subunit of PP2A in mammalian cells led to a decrease in steady-state levels of b-catenin and bcatenin reporter gene expression. In Xenopus embryos, over-expression of B56a was found to inhibit Xwnt-8-induced expression of target genes. Conversely, treatment of HEK293 cells with Okadaic acid, an inhibitor of PP2A, leads to stabilization of b-catenin. Expression of B56a was also found to synergize with GSK-3 in decreasing steady-state levels of b-catenin, suggesting that PP2A may regulate b-catenin stability through direct modulation of GSK-3 activity. However, Willert et al. (1999b) recently reported that PP2A appears to function as an activator of the Wnt/bcatenin pathway. In that study, PP2A dephosphorylated Axin in vitro, mimicking the ability of soluble Wnt-3a to promote dephosphorylation of Axin in C57MG cells. Furthermore, treatment of C57MG cells with Okadaic acid inhibited Wnt-3a, and resulted in an increase in the association of b-catenin with Axin and a decrease in b-catenin stability. There are several explanations for these discrepancies. First, PP2A is a multi-protein enzyme and the speci®c composition of subunits may alter its function depending on the cellular context. It is also possible that over-expression of the B56a regulatory subunit does not promote, but instead inhibits dephosphorylation of Wnt pathway components such as Axin. Further analysis of the eects of PP2A on the activity of the destruction complex should help clarify the relationship between PP2A and Wnt signaling.
Regulation of the destruction complex and stabilization of b-catenin
How does activation of the Wnt/b-catenin pathway promote the stabilization and formation of a free, signaling pool of b-catenin in the cell? This question has been the focus of intense research over the past several years and great strides have been made in our understanding of b-catenin regulation. At the heart of this question is our protagonist, b-catenin, its nemesis, the GSK-3/Axin/APC/b-TrCP destruction complex, and the Jedi Knights, Dishevelled (Dsh) and GBP/ Frat1, which protect b-catenin from degradation. Until recently, our knowledge of the molecular mechanism of Dsh and GBP/Frat1 function was limited, but over the past year signi®cant advances have been made. These insights have come from examination of Wnt signaling in a variety of systems using diverse approaches and lead to our current understanding of how Wnt signals regulate b-catenin stability.
Genetically, Dsh is the most upstream intracellular component of the Wnt/b-catenin pathway and is activated in response to Wnt signals (Noordermeer et al., 1994; Siegfried et al., 1994) . Dsh is a modular phosphoprotein that appears to function through its association with other signaling proteins (Figure 1 ; Axelrod et al., 1998; Boutros et al., 1998; Li et al., 1999b) . Dsh may modulate b-catenin stability through a direct interaction with the destruction complex. Dsh has been shown to bind Axin and this interaction has been proposed to result in down-regulation of GSK-3 (Kishida et al., 1999; Li et al., 1999a; Smalley et al., 1999) . Consistent with this idea, Ruel et al. (1999) reported that expression of Dishevelled in Drosophila clone 8 and S2 cells results in an approximate 70% decrease in zw3/GSK-3 activity in an in vitro kinase assay using a peptide substrate. Dishevelled expression also stimulated serine phosphorylation of GSK-3 in S2 cells suggesting that Dishevelled may regulate zw3/ GSK-3 activity via phosphorylation of zw3/GSK-3 by an unidenti®ed kinase or inhibition of an unidenti®ed phosphatase (Ruel et al., 1999) . Lee et al. (1999) also demonstrated that expression of Dishevelled in Drosophila clone 8 cells inhibited zw3/GSK-3-mediated phosphorylation of Tau protein. Furthermore, Dishevelled can diminish the phosphorylation of b-catenin and APC by GSK-3 in the presence of Axin in vitro (Kishida et al., 1999) . However, in this study Dishevelled did not block the ability of GSK-3 to phosphorylate a peptide substrate (Kishida et al., 1999) suggesting that Dishevelled inhibits Axin-stimulated GSK-3-dependent phosphorylation of b-catenin and APC via a mechanism other than a direct eect on GSK-3 kinase activity itself.
Dsh function may also be dependent on its localization within the cell. In Xenopus, the activation of a maternal Wnt/b-catenin pathway is required for the establishment of dorsal cell fates (reviewed by Moon and Kimelman, 1998) . Examination of the localization of Dsh in early embryos revealed that Dsh associates with small vesicle-like organelles (0.5 ± 1.0 mm diameter) that are enriched on the dorsal side of the embryo at the end of the ®rst cell cycle . This localization appears to be signi®cant since treatments that prevent dorsal development also block the dorsal enrichment of Dsh. Interestingly, timelapse confocal microscopy analysis of Green Fluorescent Protein tagged Dsh (Dsh-GFP) localization in early embryos demonstrated that Dsh-GFP associates with and is transported along the microtubule cytoskeleton towards the prospective dorsal side of the embryo. Dsh also localizes to small vesicle-like organelles in both mammalian and Drosophila cell lines (Lee et al., 1999; Smalley et al., 1999) . Together these data suggest that regulation of Dsh localization, perhaps through its association with the cytoskeleton, plays an important role in modulating the activity of the Wnt/b-catenin pathway.
GBP (GSK-3 Binding Protein), originally identi®ed in a yeast-two-hybrid screen using GSK-3 as bait, and its mammalian ortholog Frat1 function as positive regulators of the Wnt/b-catenin pathway. In Xenopus, over-expression of GBP/Frat1 mimics activation of the Wnt/b-catenin and results in formation of an ectopic dorsal-ventral axis (Yost et al., 1998) . Expression of GBP also results in stabilization of b-catenin. Insight into the mechanism of GBP function come from data showing that GBP antagonizes GSK-3-dependent phosphorylation of Tau both in vitro and in vivo, suggesting that it stabilizes b-catenin through inhibition of GSK-3 activity. However, it is unclear whether this eect is due to a change in GSK-3 activity or through steric blockade of GSK-3/substrate interactions.
It is possible that Dishevelled and GBP/Frat1 function independently, but recent evidence suggests that their roles in regulating b-catenin stability may be intertwined. Dishevelled and GBP/Frat1 interact in mammalian cells and Xenopus embryos (Li et al., 1999a) . Furthermore, Dishevelled and GBP/Frat1 were found in a quaternary complex with GSK-3 and Axin (Li et al., 1999a) . Interestingly, composition of this complex is regulated by Wnt-1 expression suggesting that interactions between GSK-3, Axin, Dishevelled, and GBP/Frat1 may be important for regulating bcatenin.
Current models predict that Wnt-mediated activation of Dsh and GBP/Frat1 inhibits GSK-3-mediated phosphorylation of b-catenin thereby stimulating the signaling function of b-catenin. Although this hypothesis is generally agreed upon, there is some debate concerning the mechanism by which Dsh and GBP/ Frat1 modulate GSK-3 function. Two alternative hypotheses have been proposed to explain how activation of Dsh and GBP/Frat1 lead to downregulation of GSK-3-mediated phosphorylation of bcatenin: (1) Activation directly down-regulates GSK-3 activity, or (2) Activation alters the composition of the destruction complex thereby preventing GSK-3 phosphorylation of b-catenin. Although these proposed mechanisms are not mutually exclusive and cell typespeci®c dierences may exist, they serve as a paradigm for understanding the mechanism of signal transduction through the Wnt/b-catenin pathway.
Several groups have shown that Wnt signals can inhibit GSK-3 activity. Cook et al. (1996) have shown that stimulation of mammalian cells with Wg conditioned media causes a twofold reduction in GSK-3 activity via a PKC-dependent mechanism. Likewise, stimulation of the Wnt/b-catenin pathway in Drosophila clone 8 cells via addition of soluble Wg, or expression of DFz-2 caused a decrease in zw3/GSK-3 activity in cell extracts (Ruel et al., 1999) . GSK-3 activity can also be modulated by Wnt signals in vivo. Itoh et al. (1998) have demonstrated that overexpression of Xwnt-8 in Xenopus embryos results in a decrease in GSK-3 activity associated with Axin. This eect was not due to modulation of Axin/GSK-3 interactions since expression of Xwnt-8 did not alter the levels of GSK-3 associated with Axin. Overexpression of Wg in early Drosophila embryos also resulted in a modest decrease in total zw3/GSK-3 activity (Ruel et al., 1999) . Together, these results demonstrate that Wnt signals can inhibit GSK-3 activity.
Although a case can be made for the importance of GSK-3 down-regulation in controlling b-catenin stability, several recent papers provide evidence that Wnt signals do not inhibit GSK-3 per se, but instead alter the composition of the destruction complex thereby suppressing the phosphorylation of b-catenin by GSK-3. Willert et al. (1999) showed that Wnt-3a stimulation of C57MG cells results in a reduction in the phosphorylation of Axin that coincides with a decrease in binding anity between Axin and bcatenin. Li et al. (1999) found that expression of Wnt-1 promotes the disintegration of the Axin-GSK-3-Dsh-GBP/Frat1 complex in cultured cells. A GSK-3 binding peptide from GBP/Frat1 was also shown to prevent GSK-3 interactions with Axin and GSK-3-mediated phosphorylation of Axin and b-catenin . Finally, Ruel et al. (1999) reported that addition of soluble Wg to Drosophila clone 8 cells not only suppressed the activity of zw3/ GSK-3 but also caused a decrease in its interaction with Axin. Thus, Wnt signals can also modulate the composition of the destruction complex thereby preventing GSK-3-dependent phosphorylation of bcatenin. Further biochemical analysis of the destruction complex and its regulation by Dsh and GBP/Frat1 will help resolve how Wnt signals promote the stabilization of b-catenin in the cell.
Regulation of b-catenin stability by other signaling pathways b-catenin can also be activated by Wnt-independent mechanisms. Expression of Integrin-linked kinase (ILK) in mammalian cells promotes the stabilization and nuclear accumulation of b-catenin (Novak et al., 1998) . ILK can phosphorylate and down-regulate GSK-3 activity (Delcommenne et al., 1998) suggesting that its eects on b-catenin may result from the inactivation of GSK-3. Presenilins have also been implicated as regulators of b-catenin stability (Kang et al., 1999; Tesco et al., 1998; Zhang et al., 1998) . Mutations in presenilin associated with rapid onset of Alzheimer's disease decrease the stability of b-catenin in neurons (Zhang et al., 1998) . This eect on b-catenin was also correlated with an increase in the susceptibility of neurons to apoptosis resulting from the accumulation of b-amyloid protein (Zhang et al., 1998) . Given the ability of these, and other, signaling pathways to modulate b-catenin stability, it is likely that b-catenin may regulate many diverse cellular processes independent of Wnt signaling.
Downstream of b-catenin: targets and regulation
In the presence of Wnt signals, b-catenin is stabilized and accumulates both in the cytoplasm and the nucleus (Peifer et al., 1994; Yost et al., 1996) . In the nucleus, bcatenin binds members of the TCF/LEF family of transcription factors (Figure 1, reviewed by and this complex stimulates expression of Wnt/b-catenin target genes. A number of target genes have been identi®ed in the past several years and these include developmental regulatory genes such as siamois, twin, and Xnr-3 in Xenopus (Brannon et al., 1997; Fan et al., 1998; Laurent et al., 1997; McKendry et al., 1997) , and ultrabiothorax in Drosophila (Riese et al., 1997) . Additional targets include regulators of cell growth and proliferation, c-myc and cyclin D-1 Shtutman et al., 1999; Tetsu and McCormick, 1999) , a regulator of cell ± cell communication, connexin-43 (van der Heyden et al., 1998) , and the metalloproteinase, matrilysin (Crawford et al., 1999) .
The mechanism by which b-catenin activates transcription remains unclear. Mutational analyses have identi®ed two regions of b-catenin, one near the amino-terminus and one at the carboxy-terminus, that are important for transactivation (Cox et al., 1999; Hecht et al., 1999; van de Wetering et al., 1997) . Another possible mode of action is that b-catenin binding to TCF/LEF may displace co-repressors (see below) from TCF/LEF. At this time, however, it is not known whether association of b-catenin and one of several identi®ed co-repressors with TCF/LEF is mutually exclusive.
In the absence of Wnt signals, TCF/LEF proteins can act as transcriptional repressors, preventing transcription of Wnt/b-catenin target genes. Evidence supporting this proposal came from examination of the transcriptional control of siamois in Xenopus and ubx in Drosophila (Brannon et al., 1997; Riese et al., 1997) . Mutation of the TCF/LEF binding sites in siamois and ubx reporter constructs resulted in a moderate activation of the genes in the absence of Wnt signals. TCF/LEF proteins do not appear to act as repressors on their own but require interactions with one of several recently identi®ed co-repressors including Groucho Roose et al., 1998) , CBP/p300 (Creb Binding Protein; Waltzer and Bienz, 1998) , and CtBP (C-terminal Binding Protein; Brannon et al., 1999) . The mechanism by which Groucho and CtBP repress transcription is unclear. However, Waltzer and colleagues (1999) demonstrated that CBP acetylates dTCF in vitro and that this results in a modest reduction in dTCF/Armadillo binding. These data suggest that CBP may function by modulating interactions between TCF/LEF and b-catenin raising the threshold level of b-catenin required for activation of target genes.
Recent evidence also implicates components of the mitogen-activated protein kinase (MAPK) pathway, transforming growth factor-b-activated kinase (TAK-1) and NEMO-like kinase (NLK), as antagonists of TCF function. Evidence for the involvement of TAK-1 and NLK come from genetic analyses of a Wnt signaling pathway in C. elegans Rocheleau et al., 1999) and the ability of TAK-1 and NLK to regulate b-catenin/TCF-function in vertebrates . These studies provide evidence that TAK-1 (MOM-4) stimulates NLK (LIT-1) activity . WRM-1, a C. elegans ortholog of b-catenin/Armadillo (Rocheleau et al., 1997) , also interacts with and activates NLK/LIT-1 (Rocheleau et al., 1999) . Active NLK/LIT-1 then phosphorylates TCF/POP-1 Rocheleau et al., 1999) and prevents TCF/POP-1 from binding DNA . In vertebrates and Drosophila, this would block the ability of b-catenin/TCF to activate transcription, whereas in C. elegans this would interfere with the ability of POP-1 to repress transcription. Further analyses of TAK-1/MOM-4 and NLK/LIT-1 function will help clarify how other growth-factor-mediated signaling pathways converge with the Wnt signaling pathway to modulate diverse cellular processes during development.
Oncogenic activation of the Wnt/b-catenin pathway
Researchers have long recognized the similarities between the growth and dierentiation of cells and tissues during development and the mis-regulation of these events in oncogenesis. This relationship has become more evident with the observation that many proto-oncogenes encode components of growth factormediated signal transduction pathways. The Wnt genes and components of intracellular Wnt signaling pathways provide one of the most striking examples of this connection. In particular, the discovery that activating mutations in b-catenin are associated with a variety of human cancers has fueled an extraordinary explosion of interest into the relationship between Wnt signaling and oncogenesis.
Wnt-1 was originally identi®ed as a preferred integration site for mouse mammary tumor virus in breast adenocarcinomas (Nusse and Varmus, 1982) . In addition, Wnt-1 is able to transform cultured mammary epithelial cell lines, C57MG and RAC (Brown et al., 1986; Rijsewijk et al., 1987) and transgenic mice expressing Wnt-1 in the mammary gland develop mammary epithelia hyperplasias and adenocarcinomas (Edwards et al., 1992; Tsukamoto et al., 1988) . However, in these transgenic studies, it is clear that Wnt-1 expression alone is insucient for malignant transformation and probably requires other genetic defects. Although these data make a case for Wnt-1 acting as an oncogene, mutations in Wnt-1 have not been linked to cancer in humans. However, since mutations in several components of the Wnt/b-catenin pathway are implicated in tumor formation it is likely that Wnt-1, or other Wnt proteins capable of activating the Wnt/b-catenin pathway, may act as oncogenes in humans.
Germline mutations of the APC gene lead to familial adenomatous polyposis (FAP) characterized by the development of colorectal polyps in the second to third decade of life (Groden et al., 1991; Nishisho et al., 1991) . In addition, somatic mutations of the APC gene are associated with 480% of sporadic colorectal adenomas and carcinomas (Miyoshi et al., 1992; Powell et al., 1992; Smith et al., 1993) . Greater than 95% of germline and somatic mutations of the APC gene are nonsense mutations in the 5' half of the coding sequence that result in the formation of truncated protein products (reviewed by Polakis, 1997) . The region in which these mutations accumulate has been termed the mutation cluster region (MCR). The ®nding that the APC protein binds and regulates the steady-state levels of b-catenin ((Munemitsu et al., 1995; Rubinfeld et al., 1993; Su et al., 1993) discussed above) provide the ®rst insights into how these mutations contribute to tumor formation. In colorectal adenocarcinoma cells expressing mutant APC, b-catenin was found to accumulate to high levels and expression of wild-type APC results in a dramatic reduction in b-catenin levels (Munemitsu et al., 1995) . Signi®cantly, structure-function studies demonstrated that the central third of APC is sucient and required for down-regulation of bcatenin and mutant APC proteins truncated at the MCR are incapable of promoting b-catenin degradation (Munemitsu et al., 1995) . This central region of APC contains binding sites for b-catenin and Axin as well as putative phosphorylation sites for GSK-3 (Figure 1 , (Rubinfeld et al., 1996) ) and lack of these sites is thought to explain the abnormal function of truncated APC proteins.
Introducing speci®c mutations into the murine APC gene has generated several mouse models of APC function. Deletion of the APC gene results in embryonic lethality prior to day 8 of gestation demonstrating a requirement for APC during development (Fodde et al., 1994; Moser et al., 1995; Oshima et al., 1995) . Heterozygous Min (Multiple intestinal neoplasia) mice, which harbor a germline mutation in APC, develop a severe intestinal phenotype characterized by the formation of 4100 small intestinal tumors Su et al., 1992) . APCD716 mice also develop a large number of intestinal tumors (Oshima et al., 1995) . Both of these alleles encode truncated forms of APC that lack the central region required for b-catenin regulation. A conditional mutant has also been generated to produce a truncated form of APC and upon recombination mice developed multiple colorectal adenomas within 4 weeks (Shibata et al., 1997) . In addition to the well-documented link between APC function and colorectal cancer, mutation of APC is also implicated in aggressive ®bromatosis (Alman et al., 1997; Li et al., 1998) and as a genetic modi®er of BRCA penetrance for breast cancer (Redston et al., 1998) . Consistent with this latter ®nding, Min mice are susceptible to mammary gland tumorigenesis (Bilger et al., 1996) . Together these ®ndings highlight the importance of APC in normal development and oncogenesis. The use of mouse models of APC formation will provide tools for not only investigating how mutation of APC promotes tumor formation but also for developing potential therapeutic agents.
The striking connection between APC-mediated regulation of b-catenin and oncogenesis suggested that mutations in b-catenin itself might play a role in tumor formation. Consistent with this idea, targeted mutation or deletion of the putative GSK-3 sites leads to the production of highly stable forms of b-catenin that are hyperactive (Pai et al., 1997; Yost et al., 1996) . In addition, expression of an amino-terminally truncated form of b-catenin lacking the putative GSK-3 sites in the epidermis of transgenic mice resulted in the formation of hair follicle-related tumors (Gat et al., 1998) . Cell lines harboring activating mutations of b-catenin often display high levels of both cytoplasmic and nuclear b-catenin and constitutive activation of TCF/LEF reporter constructs . These data demonstrate that increasing levels of b-catenin is sucient to promote tumor formation and implicate the amino-terminal GSK-3 sites as potential targets for the oncogenic activation of b-catenin.
Recent studies demonstrate that b-catenin is highly mutable in various types of cancer and highlight the relationship between regulation of b-catenin stability and oncogenesis. Figure 3a provides a list of reported mutations in b-catenin associated with human cancers and the tissue from which each mutant was isolated (see Figure 3 legend for a complete list of references). Strikingly, the majority of the identi®ed mutations are missense mutations in one of the putative GSK-3 phosphorylation sites (Figure 3b) . Missense mutations at D32 and G34 have also been reported. The DSG sequence along with S37 has been characterized as a ubiquitination target motif based on its similarity with Ik-B, another protein targeted for degradation by the SCF b-TrCP ubiquitin ligase complex (Chen et al., 1995 (Chen et al., , 1996 Winston et al., 1999) . In addition to missense mutations, a number of deletion mutants that remove one or more of the putative GSK-3 sites have been isolated. Together, these data strongly argue that mutations in b-catenin that enable it to evade regulation by the destruction complex play an important role in the tumorigenic transformation of many cell types.
What is the consequence of constitutive b-catenin activity? This question remains unanswered, but several recent papers provide some insight into the role b-catenin plays in tumorigenesis. Several groups demonstrated that the c-myc and cyclin D1 genes, both of which are known to promote cell proliferation, are direct targets of b-catenin Shtutman et al., 1999; Tetsu and McCormick, 1999) . c-myc is a potent oncogene that regulates cell cycle progression, promoting the G 1 /S phase transition. However, c-myc cannot transform cells on its own and requires survival cues to prevent cells from undergoing apoptosis (reviewed in Steiner, 1996; Thompson, 1998) . Thus, b-catenin may also provide cell survival signals that protect the cell from apoptosis. Consistent with this idea, Orford and colleagues (1999) demonstrated that expression in MDCK cells of wild-type b-catenin or a form of bcatenin harboring an S37A missense mutation resulted in a signi®cant increase in proliferation, and protection from anoikis (suspension-induced apoptosis). In addition, b-catenin expression attenuated the G 1 to S cell cycle block that occurs in response to DNA damage (Orford et al., 1999) . Thus, mutations in bcatenin that result in a more stable form of the protein likely lead to mis-expression of target genes, such as c-myc and cyclin D1. Expression of c-myc and cyclin D1 would then expedite the G 1 to S transition. Additionally, b-catenin may act as a survival factor protecting cells from cell death. Since the transition from G 1 to S phase requires the presence of survival factors, b-catenin may also stimulate this transition directly by preventing apoptosis and permitting cell cycle progression. Elevated b-catenin may also enhance the accumulation of additional mutations by preventing the DNA damage-induced cell cycle block.
Wnt/Ca 2+ pathway
Frizzleds can discriminate between dierent Wnt ligands and this selectivity appears to be important for determining which downstream pathway is activated in the cell. For example, expression of Rat Frizzled-1 (RFz-1), but not Rat Frizzled-2 (RFz-2), can promote the accumulation of Xwnt-8 at the cell surface and activate Wnt/b-catenin target genes (Sheldahl et al., 1999; Yang-Snyder et al., 1996) . Conversely, expression of Xwnt-5a or RFz-2, but not Xwnt-8 or RFz-1, leads to an increase in Ca 2+¯u xes in zebra®sh, and activation of PKC in Xenopus (Sheldahl et al., 1999; Slusarski et al., 1997a,b) . Using the induction of Wnt/b-catenin target genes and activation of PKC in Xenopus as assays for Frizzled activity, Sheldahl et al. (1999) pathway, may function through activation of heterotrimeric G-proteins (Sheldahl et al., 1999; Slusarski et al., 1997a) . The ability of RFz-2 to increase Ca 2+¯u xes in zebra®sh and activate to PKC in Xenopus is sensitive to pertussis toxin, suggesting that G-proteins of the Ga i or Ga o class function downstream RFz-2 in the Wnt/Ca 2+ pathway. In addition, RFz-2-mediated activation of PKC is blocked by expression of a-transducin, a treatment that is predicted to sequester bg subunits of heterotrimeric G-proteins, preventing them from activating downstream eectors (Sheldahl et al., 1999) . Consistent with the idea that some Frizzleds signal via a G-protein-dependent mechanism, Frizzled proteins share overall sequence similarity and predicted structure with many other G-protein coupled receptors (Barnes et al., 1998) . Although a compelling case can be made for the involvement of G-proteins in Frizzled-mediated signaling, it remains unclear whether G-proteins play a direct or indirect role in the Wnt/Ca 2+ pathway. Further analysis of Frizzled/G-protein interactions using chimeric inducible-Frizzled proteins or soluble Wnt should help clarify the relationship between Frizzleds and Gproteins.
Distinct roles for Wnt-5a in cell proliferation and tumor suppression?
A number of studies provide evidence that Wnt-5a is able to antagonize the Wnt/b-catenin pathway. Stable expression of Wnt-1 in C57MG mouse mammary epithelial cells results in altered cell morphology and this change can be partially blocked by expression of Wnt-5a (Olson and Gibo, 1998) . Conversely, transfection of parental C57MG cells with anti-sense Wnt-5a constructs results in cells with a morphology similar to that seen following transformation by Wnt-1 (Olson and Gibo, 1998) . In Xenopus, co-expression of Xwnt-5a with Xwnt-8 blocks the ability of Xwnt-8 to induce a secondary dorsal-ventral axis . These data suggest that one function of Wnt-5a may be to modulate the activity of the Wnt/b-catenin pathway. Although the mechanism of Wnt-5a action is unclear, it is tempting to speculate that antagonism of the Wnt/bcatenin pathway occurs via activation of the Wnt/Ca 2+ pathway. In support of this hypothesis, activation of Ca 2+ signaling in Xenopus by ectopic expression of the serotonin receptor can block activation of the Wnt/bcatenin pathway by Xwnt-8 (Slusarski et al., 1997b) . Further analyses of Wnt-5a function should help clarify the relationship between the Wnt/b-catenin and Wnt/ Ca 2+ pathways. The ability of Wnt-5a to suppress transformation by Wnt-1 suggests that Wnt-5a may act as a tumor suppressor. Consistent with this proposed role, ectopic expression of Wnt-5a in a human renal cell carcinoma cell line, RCC233, results in suppression of cell growth and a decrease in telomerase activity . In contrast, telomerase activity is increased signi®cantly in Wnt-1 induced tumors (Broccoli et al., 1996) . Stable transfection of Wnt-5a into a human uroepithelial cell line, MC-T116 resulted in a loss of tumor formation in athymic nude mice and a loss of anchorage-independent cell growth in soft agar (Olson et al., 1997) .
Does Wnt-5a function as a tumor suppressor in vivo? Wnt-5a levels are not unilaterally repressed in all human cancers. Although Wnt-5a mRNA levels are decreased in endometrial carcinoma compared to normal tissue (Bui et al., 1997) , Wnt-5a levels are up regulated in breast cancer (Iozzo et al., 1995; Lejeune et al., 1995) , lung carcinoma, metastatic melanoma, and colon carcinoma (Iozzo et al., 1995) . Furthermore, removal of Wnt-5a function in mice results in a decrease in cell proliferation suggesting a positive role for Wnt-5a in the regulation of cell growth and proliferation. Therefore, current in vivo evidence would appear to con¯ict with the concept of Wnt-5a as a tumor suppressor. However, until the mechanics of Wnt-5a signal transduction is understood in vivo, the role of Wnt-5a in carcinogenesis will remain unclear.
Summary
Over the past several years, great strides have been made in our understanding of the mechanics and functions of Wnt signaling. In particular, recent studies examining the relationship between Wnt signaling, the regulation of b-catenin stability, and oncogenesis highlight the importance of understanding how Wnt signals modulate dierent cellular processes. However, many questions remain unanswered. 
